Synthetic lethal screen using RNA interference

Details for Australian Patent Application No. 2004276823 (hide)

Owner Merck And Co., Inc Rosetta Inpharmatics LLC

Inventors Linsley, Peter S.; Kim, Annette S.; Bartz, Steven R.; Mao, Mao; Friend, Stephen H.; Cleary, Michele A.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004276823

PCT Pub. Number WO2005/031002

Priority 60/548,568 27.02.04 US; 60/554,284 17.03.04 US; 60/505,229 22.09.03 US

Filing date 22 September 2004

Wipo publication date 7 April 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/031002 Priority application(s): WO2005/031002

14 April 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004276825-Fragment complementation assays for G-protein-coupled receptors and their signaling pathways

2004276821-Novel therapeutic targets in cancer